etripamil

etripamil (CARDAMYST) is an FDA-listed pharmaceutical active ingredient. Associated with Milestone Pharmaceuticals. Route of administration: nasal. Current US regulatory status: approved.

CARDAMYST is a marketed brand name for etripamil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

etripamil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.